Effector Therapeutics competitorsClear all

Effector Therapeutics's top competitors include Cleveland BioLabs, XBiotech, Aeglea Biotherapeutics and Geron.
Effector Therapeutics
Effector Therapeutics
Effector Therapeutics is a company focused on the discovery and development of small molecule cancer therapeutics.
Cleveland BioLabs
Cleveland BioLabs
CBLI’s mission is to develop and commercialize innovative drugs to treat cancer and protect healthy tissues from radiation, chemotherapy or ischemic conditions.
XBiotech
XBiotech
XBiotech is a biopharmaceutical company developing first-in-class antibody therapies.
Aeglea Biotherapeutics
Aeglea Biotherapeutics
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.
Geron
Geron
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Founding Date
Founding Date
2012
Founding Date
2003
Founding Date
2005
Founding Date
2013
Founding Date
1990
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
Buffalo, US HQ
Locations
Austin, US HQ
Locations
Austin, US HQ
Locations
Menlo Park, US HQ
Canton, US
Employees
Employees
34
Employees
118% decrease
Employees
595% increase
Employees
619% increase
Employees
1713% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
17.3 m
Valuation ($)
259.7 m
Valuation ($)
200.6 m
Valuation ($)
261.1 m
Alexa Website Rank
Alexa Website Rank
1333237
Alexa Website Rank
1608934
Alexa Website Rank
1073009
Alexa Website Rank
714531
Alexa Website Rank
233956

Financial

Net income
Net income
N/A
Net income
($3.7m) (FY, 2018)
Net income
($21.1m) (FY, 2018)
Net income
($44.3m) (FY, 2018)
Net income
($27m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 101m
Total funding raised
$ 12.2m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 96.7m
For sources of this data, please see the company profile

View company profiles

Cleveland BioLabs
HQ
Buffalo, US
Employees
11↓ 8% decrease

CBLI’s mission is to develop and commercialize innovative drugs to treat cancer and protect healthy tissues from radiation, chemotherapy or ischemic conditions.

View company
XBiotech
HQ
Austin, US
Employees
59↑ 5% increase

XBiotech is a biopharmaceutical company developing first-in-class antibody therapies.

View company
Aeglea Biotherapeutics
HQ
Austin, US
Employees
61↑ 9% increase

Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.

View company
Geron
HQ
Menlo Park, US
Employees
17↑ 13% increase

Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

View company